It was noted in the medical journal that the subject started using his non-dominate had more often as well as holding his dominate afflicted arm closely to his body. On further examination, the child’s scapula and clavicle had totally dissipated and were no longer there to support the shoulder, making his right arm appear to hang lower the left. After the initial inspection of the child an MRI was ordered shown that the reaming scapula had turned into vascularized soft tissue, which had not shown up on an x-ray. In this case, the disease only effected the scapula and clavicle of the right side of the body, and did not affect the humerus or any adjacent bone structures. In following months the patient that the disease plateaued and had not increased in severity other than the destruction of the pectoral girdle. The only thing the disease spared was the region of the glenoid process. The medical community had made some strides in the treatment of this rare disease. The primary goal in treating this disease is to inhibit bone absorption by the body to try and keep the bone structural
It was noted in the medical journal that the subject started using his non-dominate had more often as well as holding his dominate afflicted arm closely to his body. On further examination, the child’s scapula and clavicle had totally dissipated and were no longer there to support the shoulder, making his right arm appear to hang lower the left. After the initial inspection of the child an MRI was ordered shown that the reaming scapula had turned into vascularized soft tissue, which had not shown up on an x-ray. In this case, the disease only effected the scapula and clavicle of the right side of the body, and did not affect the humerus or any adjacent bone structures. In following months the patient that the disease plateaued and had not increased in severity other than the destruction of the pectoral girdle. The only thing the disease spared was the region of the glenoid process. The medical community had made some strides in the treatment of this rare disease. The primary goal in treating this disease is to inhibit bone absorption by the body to try and keep the bone structural